PROMIS NEUROSCIENCES INC.: stockholders equity
Stockholders equity for PROMIS NEUROSCIENCES INC. Inspect selected reporting periods, original units and SEC filing links; download the financial history.
All PROMIS NEUROSCIENCES INC. financial histories
What this measure means
The reported residual interest after liabilities. It is an accounting amount, not market capitalization.
Exact concept: us-gaap:StockholdersEquity. Each value is a balance at the reporting date, not a flow earned over a year. Different units remain separate; no currency conversion or interpolation is applied.
Coverage of this history
Selected reporting periods run from 2020-12-31 to 2025-12-31. The SEC response was captured on 2026-09-20.
Selected filing history
| Period start | Period end | Value | Unit | Filed | Source filing |
|---|---|---|---|---|---|
| At date | 2025-12-31 | -1,258,592 | USD | 2026-03-25 | 10-K · 0001104659-26-034554 |
| At date | 2024-12-31 | 16,488,176 | USD | 2026-03-25 | 10-K · 0001104659-26-034554 |
| At date | 2023-12-31 | 3,753,296 | USD | 2026-03-25 | 10-K · 0001104659-26-034554 |
| At date | 2022-12-31 | -1,347,772 | USD | 2025-03-31 | 10-K · 0001558370-25-004068 |
| At date | 2021-12-31 | 5,660,058 | USD | 2024-04-01 | 10-K · 0001558370-24-004532 |
| At date | 2020-12-31 | -796,658 | USD | 2023-03-08 | 10-K · 0001558370-23-003167 |
Related financial histories
- PROMIS NEUROSCIENCES INC.: total assets
- PROMIS NEUROSCIENCES INC.: total liabilities
- PROMIS NEUROSCIENCES INC.: cash and cash equivalents
- PROMIS NEUROSCIENCES INC.: net income or loss
- PROMIS NEUROSCIENCES INC.: operating cash flow
- PROMIS NEUROSCIENCES INC.: financing cash flow
- PROMIS NEUROSCIENCES INC.: investing cash flow
- PROMIS NEUROSCIENCES INC.: retained earnings or deficit
- PROMIS NEUROSCIENCES INC.: basic weighted-average shares
- PROMIS NEUROSCIENCES INC.: diluted weighted-average shares
- PROMIS NEUROSCIENCES INC.: basic earnings per share
- PROMIS NEUROSCIENCES INC.: diluted earnings per share
- PROMIS NEUROSCIENCES INC.: share-based compensation expense
- PROMIS NEUROSCIENCES INC.: operating income or loss
- PROMIS NEUROSCIENCES INC.: current assets
- PROMIS NEUROSCIENCES INC.: current liabilities
- PROMIS NEUROSCIENCES INC.: current accounts payable
- PROMIS NEUROSCIENCES INC.: operating expenses
- PROMIS NEUROSCIENCES INC.: research and development expense
- PROMIS NEUROSCIENCES INC.: common shares outstanding
- PROMIS NEUROSCIENCES INC.: cash including restricted cash
- PROMIS NEUROSCIENCES INC.: additional paid-in capital
- PROMIS NEUROSCIENCES INC.: accumulated other comprehensive income or loss
- PROMIS NEUROSCIENCES INC.: accrued current liabilities
- PROMIS NEUROSCIENCES INC.: prepaid expenses and other current assets
- PROMIS NEUROSCIENCES INC.: profit or loss including noncontrolling interests
- PROMIS NEUROSCIENCES INC.: comprehensive income or loss
- PROMIS NEUROSCIENCES INC.: net income available to common stockholders
- PROMIS NEUROSCIENCES INC.: general and administrative expense
- PROMIS NEUROSCIENCES INC.: depreciation expense
- PROMIS NEUROSCIENCES INC.: amortization of intangible assets
- PROMIS NEUROSCIENCES INC.: other nonoperating income or expense
- PROMIS NEUROSCIENCES INC.: nonoperating income or expense
- PROMIS NEUROSCIENCES INC.: interest paid, net
- PROMIS NEUROSCIENCES INC.: proceeds from issuing common stock
- PROMIS NEUROSCIENCES INC.: change in accounts payable
Inspect the source
- Entity
- PROMIS NEUROSCIENCES INC. / CIK 0001374339
- Captured
- 2026-09-20T07:57:21.325Z
- SEC response SHA-256
5596b067574a7cc20a477d7fe8f05d7e17a50dc3ec4bb50162e42b7bc31f01dd
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Latest-filed annual-report facts per unit and reporting period at capture time. Duration facts cover 300 to 400 days. This selection can include restatements and is not a point-in-time backtest dataset. Missing concepts are omitted, never zero-filled. Values retain original units and are not currency converted. Extended concepts require compatible unit shapes and at least three reporting ends with changing values within one unit. Constant or incompatible added histories are omitted.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0001374339.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))